Parkinson’s Disease Drugs Market Size, Share and Industry Analysis By Drug Class (Decarboxylase Inhibitors, Dopamine Agonists, Monoamine Oxidase Type B (MAO-B) Inhibitor, Catechol-O-Methyltransferase (COMT) Inhibitors), Route of Administration (Oral, Injection, Transdermal), Distribution Channels (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) & Regional Forecast, 2019 - 2026
The global parkinson’s disease drugs market size was valued at USD 4,500.0 Million in 2018, is projected to reach USD 8,383.2 Million by the end of 2026, exhibiting... Read More
Region : Global | Published Date: Jun, 2019 | Report ID: FBI100655 | Status : Published
Request Sample PDF
- 2018
- 2014-2018
- 133
Healthcare Clients
- Get in Touch with Us
-
-
